Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
40 studies found for:    " December 16, 2009":" January 15, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Unknown  A Pilot Study of Kaletra and Intelence Tablets in Naive Subjects
Condition: HIV Infections
Intervention: Drug: Kaletra and Intelence Tablets
22 Completed Observational Study of Blood Treated With Cytolin
Condition: HIV Infections
Intervention:
23 Unknown  Lopinavir/Ritonavir or Efavirenz as First-line Antiretroviral Therapy
Condition: HIV Infections
Intervention: Drug: First-line Antiretroviral Therapy
24 Completed
Has Results
Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: ARV (non-raltegravir)
25 Active, not recruiting The Impact of Omega Three Fatty Acids on Vascular Function in HIV
Conditions: High Triglyceride Level;   HIV Infection
Intervention: Drug: Lovaza
26 Completed The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
Condition: HIV Infections
Intervention:
27 Completed Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity
Conditions: Treatment Failure, HIV or AIDS;   CD4 Cell Counts
Intervention: Drug: Efavirenz-based regimens
28 Suspended Sexually Transmitted Infections Among African American Women Who Have Sex With Women
Conditions: Sexually Transmitted Infections;   HIV Infections
Intervention:
29 Completed
Has Results
Concentrations of Raltegravir in the Semen of HIV-Infected Men
Condition: HIV
Intervention: Other: Seminal plasma pharmacokinetics
30 Completed ID & Testing in Male Partners
Condition: HIV
Intervention:
31 Completed Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression
Condition: HIV
Interventions: Drug: Etravirine 400 mg dissolved in water every 24 hours;   Drug: Continue with the same antiretroviral regimen
32 Recruiting Cohort of HIV Associated Lymphomas
Condition: HIV Infection
Intervention:
33 Completed Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Echinacea
34 Completed Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects
Condition: HIV Infections
Intervention: Drug: Raltegravir plus Darunavir/ritonavir
35 Completed Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients
Conditions: HIV Infections;   Influenza
Intervention: Biological: naso-pharyngeal swab
36 Completed Immunology of the Infection Perinatal
Condition: HIV Infections
Intervention: Biological: A single blood sample (30 mL)
37 Terminated
Has Results
Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy
Condition: Neuropathy
Interventions: Drug: pregabalin;   Drug: placebo
38 Active, not recruiting Familias Unidas: Preventing Substance Abuse in Hispanic Youth
Conditions: Prevention;   Family Function;   Substance Use;   Sexual Behavior
Intervention: Behavioral: Familias Unidas
39 Completed Family to Family: Psychoeducation to Improve Children's Outcomes in HIV+ Families
Conditions: Quality of Life;   Family Relations;   Mental Health;   Physical Health
Intervention: Behavioral: Cognitive behavioral sessions
40 Completed Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection
Condition: Hepatitis
Intervention: Biological: Hepatitis A vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page   
Indicates status has not been verified in more than two years